Suppr超能文献

埃德蒙顿症状评估系统身体、情感及总症状困扰评分的最小临床重要差异

Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.

作者信息

Hui David, Shamieh Omar, Paiva Carlos Eduardo, Khamash Odai, Perez-Cruz Pedro Emilio, Kwon Jung Hye, Muckaden Mary Ann, Park Minjeong, Arthur Joseph, Bruera Eduardo

机构信息

Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

Department of Palliative Care, King Hussein Cancer Center, Amman, Jordan.

出版信息

J Pain Symptom Manage. 2016 Feb;51(2):262-9. doi: 10.1016/j.jpainsymman.2015.10.004. Epub 2015 Oct 19.

Abstract

CONTEXT

The Edmonton Symptom Assessment System (ESAS) is one of the most commonly used symptom batteries in clinical practice and research.

OBJECTIVES

We used the anchor-based approach to identify the minimal clinically important difference (MCID) for improvement and deterioration for ESAS physical, emotional, and total symptom distress scores.

METHODS

In this multicenter prospective study, we asked patients with advanced cancer to complete their ESAS at the first clinic visit and at a second visit three weeks later. The anchor for MCID determination was Patient's Global Impression regarding their physical, emotional, and overall symptom burden ("better," "about the same," or "worse"). We identified the optimal sensitivity/specificity cutoffs for both improvement and deterioration for the three ESAS scores and also determined the within-patient changes.

RESULTS

A total of 796 patients were enrolled from six centers. The ESAS scores had moderate responsiveness, with area under the receiver operating characteristic curve between 0.69 and 0.76. Using the sensitivity-specificity approach, the optimal cutoffs for ESAS physical, emotional, and total symptom distress scores were ≥3/60, ≥2/20, and ≥3/90 for improvement, and ≤-4/60, ≤-1/20, and ≤-4/90 for deterioration, respectively. These cutoffs had moderate sensitivities (59%-68%) and specificities (62%-80%). The within-patient change approach revealed the MCID cutoffs for improvement/deterioration to be 3/-4.3 for the physical score, 2.4/-1.8 for the emotional score, and 5.7/-2.9 for the total symptom distress score.

CONCLUSION

We identified the MCIDs for physical, emotional, and total symptom distress scores, which have implications for interpretation of symptom response in clinical trials.

摘要

背景

埃德蒙顿症状评估系统(ESAS)是临床实践和研究中最常用的症状评估量表之一。

目的

我们采用基于锚定的方法来确定ESAS身体、情绪及总症状困扰评分改善和恶化的最小临床重要差异(MCID)。

方法

在这项多中心前瞻性研究中,我们要求晚期癌症患者在首次门诊就诊时及三周后的第二次就诊时完成ESAS评估。用于确定MCID的锚定指标是患者对其身体、情绪及总体症状负担的整体印象(“好转”“大致相同”或“恶化”)。我们确定了三个ESAS评分改善和恶化的最佳灵敏度/特异度临界值,并确定了患者内变化情况。

结果

共从六个中心招募了796名患者。ESAS评分具有中等反应性,受试者工作特征曲线下面积在0.69至0.76之间。采用灵敏度-特异度方法,ESAS身体、情绪及总症状困扰评分改善的最佳临界值分别为≥3/60、≥2/20和≥3/90,恶化的最佳临界值分别为≤ -4/60、≤ -1/20和≤ -4/90。这些临界值具有中等灵敏度(59%-68%)和特异度(62%-80%)。患者内变化方法显示,身体评分改善/恶化的MCID临界值为3/-4.3,情绪评分为2.4/-1.8,总症状困扰评分为5.7/-2.9。

结论

我们确定了身体、情绪及总症状困扰评分的MCID,这对解释临床试验中的症状反应具有重要意义。

相似文献

1
Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.
J Pain Symptom Manage. 2016 Feb;51(2):262-9. doi: 10.1016/j.jpainsymman.2015.10.004. Epub 2015 Oct 19.
3
Minimal clinically important differences in the Edmonton symptom assessment system in patients with advanced cancer.
J Pain Symptom Manage. 2013 Aug;46(2):192-200. doi: 10.1016/j.jpainsymman.2012.07.022. Epub 2012 Nov 22.
4
Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
J Pain Symptom Manage. 2016 Feb;51(2):292-7. doi: 10.1016/j.jpainsymman.2015.09.011. Epub 2015 Oct 24.
7
Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.
J Pain Symptom Manage. 2015 May;49(5):945-52. doi: 10.1016/j.jpainsymman.2014.10.013. Epub 2014 Dec 15.
8
Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden.
Palliat Support Care. 2018 Feb;16(1):14-22. doi: 10.1017/S1478951517000098. Epub 2017 Mar 7.
9
Establishing minimal clinically important differences for the Pemphigus Disease Area Index.
Br J Dermatol. 2024 Oct 17;191(5):823-831. doi: 10.1093/bjd/ljae283.
10
The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression.
Eur J Cancer Care (Engl). 2013 Jan;22(1):60-9. doi: 10.1111/j.1365-2354.2012.01369.x. Epub 2012 Jun 14.

引用本文的文献

2
Palliative Video Consultation and Symptom Distress Among Rural Inpatients: A Randomized Clinical Trial.
JAMA Netw Open. 2025 Jul 1;8(7):e2519426. doi: 10.1001/jamanetworkopen.2025.19426.
4
Nutrition Assessment and Counseling in Integrative Cancer Care: Effects on Patient Self-Reported Symptoms.
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251342756. doi: 10.1177/15347354251342756. Epub 2025 May 24.
5
Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021.
JCO Oncol Pract. 2025 Mar 26:OP2400782. doi: 10.1200/OP-24-00782.
10
Frequency and Characteristics of Integrative Oncology Referrals for Patients With Cancer Receiving Inpatient Rehabilitation.
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241296810. doi: 10.1177/15347354241296810.

本文引用的文献

2
Screening for body image dissatisfaction in patients with advanced cancer: a pilot study.
J Palliat Med. 2015 Feb;18(2):151-6. doi: 10.1089/jpm.2013.0588. Epub 2014 Sep 4.
3
A personalized approach to assessing and managing pain in patients with cancer.
J Clin Oncol. 2014 Jun 1;32(16):1640-6. doi: 10.1200/JCO.2013.52.2508. Epub 2014 May 5.
4
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial.
Lancet. 2014 May 17;383(9930):1721-30. doi: 10.1016/S0140-6736(13)62416-2. Epub 2014 Feb 19.
5
Prediction of immediate postoperative pain using the analgesia/nociception index: a prospective observational study.
Br J Anaesth. 2014 Apr;112(4):715-21. doi: 10.1093/bja/aet407. Epub 2013 Dec 8.
6
Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.
J Pain Symptom Manage. 2013 Dec;46(6):947-56. doi: 10.1016/j.jpainsymman.2013.01.012. Epub 2013 Apr 28.
7
Minimal clinically important differences in the Edmonton symptom assessment system in patients with advanced cancer.
J Pain Symptom Manage. 2013 Aug;46(2):192-200. doi: 10.1016/j.jpainsymman.2012.07.022. Epub 2012 Nov 22.
8
Validity of four pain intensity rating scales.
Pain. 2011 Oct;152(10):2399-2404. doi: 10.1016/j.pain.2011.07.005.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验